Hudson Bay Capital Management’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Hudson Bay Capital Management’s Portfolio SBFMW Stock Details SBFMW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-60,000	Closed	-$59K	–	1408
2022 Q1	$59K	Buy	+60,000	New	+$41.9K	﹤0.01%	996

Other funds holding SBFMW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Hudson Bay Capital Management's SBFMW Position: Q2 2022 in Review

Hudson Bay Capital Management sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q2 2022, closing a stake of 60,000 shares — an estimated $59K sold.

Hudson Bay Capital Management first reported a position in SBFMW in Q1 2022 and held it in 1 quarter. The position peaked at $59K in Q1 2022. 4 funds tracked by Wall St. Rank hold SBFMW as of Q2 2022.

Hudson Bay Capital Management reported no remaining Sunshine Biopharma Inc Warrant position as of Q2 2022 after selling out during the quarter.
Hudson Bay Capital Management sold 60,000 Sunshine Biopharma Inc Warrant shares in Q2 2022, an estimated $59K.
Hudson Bay Capital Management first reported a position in Sunshine Biopharma Inc Warrant in Q1 2022 and held it in 1 quarter.
Hudson Bay Capital Management's Sunshine Biopharma Inc Warrant position peaked at $59K in Q1 2022.
4 funds tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q2 2022.

Based on Hudson Bay Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.